Plasma miRNAs might be promising biomarkers of chronic obstructive pulmonary disease
- PMID: 25102970
- DOI: 10.1111/crj.12194
Plasma miRNAs might be promising biomarkers of chronic obstructive pulmonary disease
Abstract
Background and aims: We previously showed that microRNAs (miRNAs) in plasma are potential biomarkers for cigarette smoking-related lung fibrosis. Here, we want to find out promising miRNAs for early detection of chronic obstructive pulmonary disease (COPD).
Methods and results: Plasma miRNAs profiling was performed in COPD patients, asthma patients, and matched healthy controls. There was a >2-fold changes for all signature miRNAs between the COPD and control samples, with P values of < 0.05. Pathway analysis, taking into account enriched target mRNAs for these signature miRNAs, was also carried out. We found seven miRNAs were special expression in the COPD patients. Furthermore, changes of miR-145-5p, miR-338-3p and miR-3620-3p were consistent with the classification of new ABCD classification of COPD. Targeted gene promising proved those miRNAs acted in inflammatory mediators, regulation of proliferation and differentiation, oxidative stress and so on.
Conclusions: These results suggested that plasma miRNAs could be potential specific biomarker for early detection COPD.
Keywords: COPD; biomarkers; plasma miRNAs; smoking.
© 2014 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd.
Similar articles
-
Repression of Toll-like receptor-4 by microRNA-149-3p is associated with smoking-related COPD.Int J Chron Obstruct Pulmon Dis. 2017 Feb 22;12:705-715. doi: 10.2147/COPD.S128031. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28260877 Free PMC article.
-
An increased ratio of serum miR-21 to miR-181a levels is associated with the early pathogenic process of chronic obstructive pulmonary disease in asymptomatic heavy smokers.Mol Biosyst. 2014 May;10(5):1072-81. doi: 10.1039/c3mb70564a. Mol Biosyst. 2014. PMID: 24556821
-
Clinical relevance of plasma miR-106b levels in patients with chronic obstructive pulmonary disease.Int J Mol Med. 2013 Mar;31(3):533-9. doi: 10.3892/ijmm.2013.1251. Epub 2013 Jan 21. Int J Mol Med. 2013. PMID: 23338559
-
The roles of microRNAs in the pathogenesis of chronic obstructive pulmonary disease.Int Immunopharmacol. 2019 Feb;67:335-347. doi: 10.1016/j.intimp.2018.12.013. Epub 2018 Dec 19. Int Immunopharmacol. 2019. PMID: 30578969 Review.
-
[MicroRNAs--new biomarkers of respiratory tract diseases].Pneumonol Alergol Pol. 2014;82(2):183-90. doi: 10.5603/PiAP.2014.0024. Pneumonol Alergol Pol. 2014. PMID: 24615202 Review. Polish.
Cited by
-
Peripheral leukocyte microRNAs as novel biomarkers for COPD.Int J Chron Obstruct Pulmon Dis. 2017 Apr 6;12:1101-1112. doi: 10.2147/COPD.S130416. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28435243 Free PMC article.
-
MicroRNAs as potential targets for progressive pulmonary fibrosis.Front Pharmacol. 2015 Nov 5;6:254. doi: 10.3389/fphar.2015.00254. eCollection 2015. Front Pharmacol. 2015. PMID: 26594173 Free PMC article. Review.
-
Airway smooth muscle inflammation is regulated by microRNA-145 in COPD.FEBS Lett. 2016 May;590(9):1324-34. doi: 10.1002/1873-3468.12168. Epub 2016 Apr 19. FEBS Lett. 2016. PMID: 27060571 Free PMC article.
-
Diagnostic Potential of Extracellular MicroRNA in Respiratory Diseases.Clin Rev Allergy Immunol. 2018 Jun;54(3):480-492. doi: 10.1007/s12016-016-8589-9. Clin Rev Allergy Immunol. 2018. PMID: 27677501 Review.
-
Pulmonary EV miRNA profiles identify disease and distinct inflammatory endotypes in COPD.Front Med (Lausanne). 2022 Dec 15;9:1039702. doi: 10.3389/fmed.2022.1039702. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36590967 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical